Keratoconjunctivitis Sicca

Everything about dry eye disease is hard.

Lower Schirmer’s test score correlated with increased corneal staining and more severe disease burden among patients with dry eye disease, according to research presented at the Association for Research in Vision and Ophthalmology meeting.

Klarity-C was a suitable alternative treatment for patients with dry eye disease, according to a study published in Clinical Ophthalmology.

Sun Pharmaceutical Industries announced the U.S. launch of Cequa, a topical ophthalmic treatment indicated to increase tear production in patients with keratoconjunctivitis sicca.